[TH-302: a new hypoxia-activated cytostatic agent in pancreatic cancer treatment].

Authors	Claudia Schmalz, Jürgen Dunst
Journal	Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 191 Issue 10 Pg. 819-20 (Oct 2015) ISSN: 1439-099X [Electronic] Germany
Vernacular Title	TH-302 - ein neues unter Hypoxie aktiviertes Zytostatikum beim Pankreaskarzinom.
PMID	26385861 (Publication Type: Journal Article, Comment)
Topics	Antineoplastic Combined Chemotherapy Protocols (therapeutic use) Humans Male Pancreatic Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!